Tables at a glance

Table 1

Table 2

Table 3

Table 4

Figures at a glance

Comments

Figure 1

Comments

Figure 2

Comments

Figure 3

Table 1

Parameters	Values
Hemoglobin: Hb <9 g/dl (27%) 9 g/dl <Hb <11 g/dl (56%) Hb > 11 g/dl (17%)	2,3 - 13,4 g/dl
MCV	44 - 115 μ³,
MCHC	15 - 32,9
RBC	3000 - 6000/mm3
platelets	54000/mm3 - 315000/mm3
Reticulocytes	15500 - 945000 g/l

Table 1: Variable parameters in blood count of hemoglobinopathies patients

Table 2

		Sum of squares	ddl	Mean of squares	F	Signification
HB_A2 Low limit	Intergroupes	1532,832	25	61,313	145,761	0 ,000
	Intra-groupes	55,525	132	0 ,421
	Total	1588,357	157
HB_A2 High limit	Intergroupes	1502,218	25	60,089	138,617	0 ,000
	Intra-groupes	57,220	132	0 ,433
	Total	1559,438	157

Table 2: ANOVA TEST of HbA2 values in pathological patients

Table 3

DISEASE TYPE	Hb Anomalies	Percentage	Total
Beta- thalassemia (BT)	HTZ BT	14%	17%
Beta- thalassemia (BT)	HMZ BT	3%	17%
Drepanocytosis (S)	A /S	7,5%	10,5%
Drepanocytosis (S)	SS OU SB	3%	10,5%
Hemoglobin C	CC	2%	6,6%
	CA	4%
	C Beta-thalassemia	0.6%
Alpha-thalassemia	Alpha	1,2%	1,2%
Iron deficiency	Carence	14,5%	14,5%
Elevated Hb F	HbF <5% (nl Hemogram)	4,4%	4,4%
Delta-BT	Hb F>5% (Hb A2 normal or low)	2,5%	2,5%
Hb O Arabe	HTZ O Arabe Hb	0,6%	1,2%
Hb O Arabe	O Arabe/ BT	0,6%	1,2%

Table 3: Hemoglobinopathies profile in southern Morocco (this study).

Table 4

Hb Type	Type	HB_A2	HB_A2Bis	HB_F	HB_FBis
AA	NORMAL	2,6	3,2	1,6	1,9
HTZ Beta- Thalassemia	A / BT	4,3	7,2	0,0	3,7
HTZ Beta- Thalassemia	B/B	3,1	7,3	25,9	97,9
Drepanocytosis	S/S	2,2	6,2	6,8	21,3
	S /B	0,3	3,3	11,2	14,1
	A/S	2,8	4,4	0,0	2,9
Hemoglobin C	AC	2,8	3,3	0,2	0,4
	C/B	4,3	4,8	0,8	1,0
	CC	0,0	3,8	0,0	0,6
Delta beta thal	Delta BT	2,0	2,8	5,5	9,2
00%<Hb F<5%	Elevated Hb F	2,8	2,9	1,6	2,3
Alpha thalassemia	Minor alpha thalassemia	1,7	2,5	,0	0,0
O Arabe Hb	O arabe /BT	6,0	6,4	9,3	10,3
O Arabe Hb	Htz O Arabe	39,4	40,0	,0	,0

Table 4: Hb A2 and F Values Means in Different Hemoglobinopathies Type in Our Study.

FIGURE 1

Figure 1: Classes Age in Southern Moroccan Hemoglobinopathies Patients.

FIGURE 2

Figure 2: Clinical features in patients with hemoglobinopathy.

FIGURE 3

Figure 3: Hemoglobinopathies profile in southern Morocco (this study).